Abbott India Limited

NSE ABBOTINDIA.NS

Abbott India Limited EBIT for the year ending March 31, 2024: USD 195.02 M

Abbott India Limited EBIT is USD 195.02 M for the year ending March 31, 2024, a 24.63% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.

Abbott India Limited EBIT for the year ending March 31, 2023 was USD 156.47 M, a 8.49% change year over year.
Abbott India Limited EBIT for the year ending March 31, 2022 was USD 144.23 M, a 12.21% change year over year.
Abbott India Limited EBIT for the year ending March 31, 2021 was USD 128.54 M, a 19.41% change year over year.
Abbott India Limited EBIT for the year ending March 31, 2020 was USD 107.65 M, a 7.04% change year over year.

Key data

Date	EBIT	EBITDA	Net Income	EPS (Diluted)

NSE: ABBOTINDIA.NS

Abbott India Limited

CEO	Ms. Swati Dalal
IPO Date	Aug. 12, 2002
Location	India
Headquarters	Godrej BKC
Employees	3,814
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, pain management, pre-term labor, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was incorporated in 1944 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.

Key trends

Past 5 years